3E0M304
3E0M304 — Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Percutaneous Approach
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduce of Liquid Brachy into Periton Cav, Perc Approach
How 3E0M304 is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration — What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective — the verb of the procedure
- MBody partThe specific site
- 3ApproachHow the site was reached
- 0DeviceWhat was left in place, if anything
- 4QualifierA further distinction where one applies
Codes near 3E0M304
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- 3E0L3TZIntroduction of Destructive Agent into Pleural Cavity, Percutaneous Approach
- 3E0L45ZIntroduction of Adhesion Barrier into Pleural Cavity, Percutaneous Endoscopic Approach
- 3E0L4GCIntroduction of Other Therapeutic Substance into Pleural Cavity, Percutaneous Endoscopic Approach
- 3E0L704Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Via Natural or Artificial Opening
- 3E0L705Introduction of Other Antineoplastic into Pleural Cavity, Via Natural or Artificial Opening
- 3E0L70MIntroduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening
- 3E0L7SFIntroduction of Other Gas into Pleural Cavity, Via Natural or Artificial Opening
- 3E0M05ZIntroduction of Adhesion Barrier into Peritoneal Cavity, Open Approach
- 3E0M304Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Percutaneous Approach
- 3E0M305Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach
- 3E0M30MIntroduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach
- 3E0M30YIntroduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach
- 3E0M328Introduction of Oxazolidinones into Peritoneal Cavity, Percutaneous Approach
- 3E0M329Introduction of Other Anti-infective into Peritoneal Cavity, Percutaneous Approach
- 3E0M33ZIntroduction of Anti-inflammatory into Peritoneal Cavity, Percutaneous Approach
- 3E0M35ZIntroduction of Adhesion Barrier into Peritoneal Cavity, Percutaneous Approach
- 3E0M36ZIntroduction of Nutritional Substance into Peritoneal Cavity, Percutaneous Approach